Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
angiotensin/atrophy
Link salvestatakse lõikelauale
Leht 1 alates 63 tulemused
Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Biophytis is developing BIO101, an investigational new drug, an oral preparation of immediate-release 20-hydroxyecdysone (20E) at ≥ 97% purity. BIO101 activates MasR on the protective arm of the Renin Angiotensin System (RAS). The engagement of MasR by BIO101 is responsible for a number of
To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. Aim- To compare the efficacy of albumin when compared to placebo in the development or progression of AKI in patients with cirrhosis and spontaneous bacterial peritonitis who are at low risk for AKI development (i.e Serum Bilirubin <4 mg/dL and serum creatinine < 1 mg/dl at presentation)
-
TXA COVID-19 Clinical Trial
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
After being informed about the study and potential risks, all patients giving written informed consent will be randomized in a double-blinded manner (participant and investigator are blinded to drug/placebo administration) and will undergo a 7 day treatment with either placebo or study drug. The
COVID-19 Related Lockdown Effects On Chronic Diseases
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Atorvastatin as Adjunctive Therapy in COVID-19
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
COVID-19 is caused by SARS-CoV-2, a β-coronavirus that binds to the zinc peptidase angiotensin-converting enzyme 2 (ACE2). No drug is licensed to treat COVID-19, but adjunctive pharmacologic interventions have been proposed for their immunomodulatory effects, including statins. About 5% of cases are
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Captopril Versus Atenolol to Prevent Expansion Rate of Thoracic Aortic Aneurysms
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Heart failure (HF) is emerging as an epidemic in 3rd world countries. Despite significant therapeutic advances, patients with chronic heart failure remain at high risk for HF progression and death. The two primary goals of its management are preventing further disease progression(mortality,
MRA and ARB Treatment in Screening of Primary Aldosteronism
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Primary aldosteronism (PA) is a common form of hypertension caused by aldosterone secretion inappropriate for blood pressure (BP) and volume status. It involves over 11% of the patients referred to specialized hypertension centres, about one fifth of those with drug-resistant hypertension and even a
Ultrafiltration Versus Diuretics in Management of Cardiorenal Syndrome
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Heart failure (HF) is a major public health problem with a prevalence of more than 23 million worldwide(Roger VL: Epidemiology of heart failure. Circ Res 2013). Acute decompensated HF (ADHF), defined as 'gradual or rapid change in HF signs and symptoms resulting in a need for urgent therapy', with
Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Peritoneal dialysis (PD) is one of the methods of renal replacement therapy (RRT) that can easily perform at home. The declared "PD first" policy from the National Health Security Office causes rapidly expansion of this group of patients. In the year 2013, the current study in Thailand showed that
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Effectiveness of Combined Aerobic and Strength Training in Acute and Chronic Adaptations in Patients With Heart Failure
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Literature Review:CHF is the major public health problem in the world[1], highly prevalent in older individuals and a major cause of disability, hospitalizations, morbidity and mortality[2]. Generally, CHF patients have reduced exercise capacity, with main symptoms of effort intolerance, early
The African-PREDICT Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background and Problem Statement: Recent global analyses have indicated that the highest blood pressures worldwide are recorded in black populations. The vulnerable cardiovascular profile of Africans is believed to result from a combination of factors such as rapid urbanisation, abnormal sodium
A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Amiloride is a Na+ channel blocker and has been used as a diuretic. It mainly inhibits the exchange of Na+-K+ and Na+-H+ in the distal tubule and collecting duct of the kidney, thus increasing the excretion of Na+ and water, reducing the excretion of K+ and H+. Recent studies have found a
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
